Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| FourWorld Capital Management LLC | 1.45M | $8.0M | 34.08% | -- | 2026-06-30 |
| Calamos Advisors LLC | 1.00M | -- | 23.50% | -- | 2026-06-30 |
| Parallax Volatility Advisers, L.P. | 790.9K | -- | 18.59% | -- | 2026-06-30 |
| Greenland Capital Management LP | 703.0K | -- | 16.52% | -- | 2026-06-30 |
| Polar Asset Management Partners Inc. | 700.0K | -- | 16.45% | -- | 2026-06-30 |
| MMCAP International Inc. SPC | 650.0K | -- | 15.28% | -- | 2026-06-30 |
| Linden Advisors LP | 650.0K | -- | 15.28% | -- | 2026-06-30 |
| Clear Street Group Inc. | 282.8K | -- | 6.65% | -- | 2026-06-30 |
| ARISTEIA CAPITAL, L.L.C. | 245.2K | -- | 5.76% | -- | 2026-06-30 |
| WOLVERINE ASSET MANAGEMENT LLC | 200.6K | -- | 4.72% | -- | 2026-06-30 |
